Novel blood biomarkers for heart failure mortality: mechanistic pathways, aging biology, and risk stratification

Xiaofeng Zeng, Wenwu Cheng, Yan Jiang, Li Mo · 2026

Read Novel blood biomarkers for heart failure mortality: mechanistic pathways, aging biology, and risk stratification by Xiaofeng Zeng, Wenwu Cheng, Yan Jiang, Li Mo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13617332.txt.

Description

Xiaofeng Zeng and three co-authors review new blood markers for death risk in heart failure in a paper from 2026. Standard markers capture only part of the risk, since death in heart failure grows out of many body systems at once, above all in older patients. The review groups markers by the pathway they reflect, from heart strain and scarring to vessel aging and kidney reserve.

Aging itself shifts marker levels through low-grade inflammation, stiff vessels, and slower clearance, so cut points need care. The authors propose a pathway-based frame for reading several markers together. They stress that the frame is a concept to be tested, not a proven clinical tool.

Catalog record

CREATORXiaofeng Zeng, Wenwu Cheng, Yan Jiang, Li Mo
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE40 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13617332

Browse the full library · About the Tower of Babel